Effect of Buformin and Metformin on Formation of Advanced Glycation End Products by Methylglyoxal

Overview

Journal Clin Chim Acta

Specialty Biochemistry

Date 2005 Jun 11

PMID 15946656

Citations 29

Authors

Tadashi Kiho

Motohiro Kato

Shigeyuki Usui

Kazuyuki Hirano

Affiliations

Soon will be listed here.

Abstract

Background: The formation and accumulation of advanced glycation end products (AGE) in various tissues are known to be involved in the aging process and complications of long-term diabetes. Aminoguanidine as AGE inhibitors was first studied, and metformin as biguanide compounds have been reported to react with reactive dicarbonyl precursors such as methylglyoxal.

Methods: We studied the effects of the biguanides of buformin and metformin on AGE formation by the methods of specific fluorescence, and enzyme-linked immunosorbent assay and a Western blot analysis using the anti-AGE antibody after incubating BSA or RNase with methylglyoxal.

Results: Buformin is a more potent inhibitor of AGE formation than metformin, and suggests that the amino group of buformin trap the carbonyl group of methylglyoxal to suppress formation of AGE.

Conclusion: In addition to that of metformin, buformin may be clinically useful to prevent diabetic complications.

Citing Articles

Glucoselysine, a unique advanced glycation end-product of the polyol pathway and its association with vascular complications in type 2 diabetes.

Yamaguchi H, Matsumura T, Sugawa H, Niimi N, Sango K, Nagai R J Biol Chem. 2024; 300(7):107479.

PMID: 38879006 PMC: 11283207. DOI: 10.1016/j.jbc.2024.107479.

Metabolomic Comparison of Guava ( L.) Leaf Extracts Fermented by and and Their Antioxidant and Antiglycation Activities.

Jun B, Kim S, Kim S, Hong S, Lee H, Lim Y Nutrients. 2024; 16(6).

PMID: 38542752 PMC: 10974377. DOI: 10.3390/nu16060841.

Guanidine dicycloamine-based analogs: green chemistry synthesis, biological investigation, and molecular docking studies as promising antibacterial and antiglycation leads.

El-Remaily M, Aboelez M, Ezelarab H, Selim H, Taha E, Mohamed S Mol Divers. 2024; 28(6):4277-4299.

PMID: 38324159 DOI: 10.1007/s11030-024-10816-w.

Methylglyoxal in Cardiometabolic Disorders: Routes Leading to Pathology Counterbalanced by Treatment Strategies.

Berdowska I, Matusiewicz M, Fecka I Molecules. 2023; 28(23).

PMID: 38067472 PMC: 10708463. DOI: 10.3390/molecules28237742.

Dieckol, Derived from the Edible Brown Algae Attenuates Methylglyoxal-Associated Diabetic Nephropathy by Suppressing AGE-RAGE Interaction.

Cho C, Yoo G, Kim M, Kurniawati U, Choi I, Lee S Antioxidants (Basel). 2023; 12(3).

PMID: 36978839 PMC: 10045168. DOI: 10.3390/antiox12030593.